Sales and Marketing

Showing 15 posts of 11527 posts found.

‘Printed’ eye cells could herald new treatments

December 24, 2013 Research and Development, Sales and Marketing biofabrication, blind, blindness, eye printing

Researchers from Cambridge University have printed new eye cells using a standard printer that could herald new treatments to stop …

Symphogen hires non-executive director

December 24, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing symphogen

Sweden-based Biopharma firm Symphogen has appointed Annika Espander Jansson as a non-executive director to its board. Jansson has over 20 …

Boehringer launches psychiatric research project

December 23, 2013 Research and Development, Sales and Marketing Boehringer, circuit, psychiatry

Boehringer Ingelheim has announced it will collaborate on a new three-year programme to investigate the neural foundations of psychiatric disorders.  …

Thyroid cancer, TB resistance drugs top EMA approvals

December 23, 2013 Sales and Marketing EMA, TB, thyroid

The European Medicines Agency has shown the green light to a new treatment for thyroid cancer and one for drug …

Board changes at Bayer

December 23, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, malik

Bayer has appointed Kemal Malik to its management board with responsibility for innovation, succeeding Wolfgang Plischke who is retiring. Bayer …

ABPI appoints Weber Shandwick for comms support

December 20, 2013 Medical Communications, Sales and Marketing PR, Weber shandwick, apbi, comms, digital, luther

The Association of the British Pharmaceutical Industry has taken on Weber Shandwick to lead its public affairs and communications strategy. …

Wellcome Trust makes $100m from Twitter shares

December 20, 2013 Medical Communications, Sales and Marketing Francis Crick Institute, Twitter, University College London, University of Cambridge, University of Oxford, Wellcome Trust

The Wellcome Trust has walked away with a profit of more than $100 million from a previously undisclosed investment in …

Merck, Reckitt Benckiser fined by French watchdog

December 20, 2013 Manufacturing and Production, Sales and Marketing FCA, Merck, Reckitt Benckiser, generics, subutex

Merck & Co and Reckitt Benckiser have collectively been fined millions of euros by French authorities over their role in …

New managing director for UBM Live in Amsterdam

December 20, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ubm live, van der walk

Events-led marketing and comms firm UBM Live has appointed John van der Valk as the new managing director for its …

New chief executive for Gates Foundation

December 19, 2013 Research and Development, Sales and Marketing Gates, Gates Foundation, Susan Desmond-Hellmann, uccsf

The Bill & Melinda Gates Foundation has picked Susan Desmond-Hellmann as its next chief executive. Desmond-Hellmann sits on the boards …

BMS sells diabetes stake to partner AstraZeneca

December 19, 2013 Sales and Marketing AstraZeneca, BMS, Forxiga, Onglyza, diabetes, komboglyze

AstraZeneca will buy out Bristol-Myers Squibb’s stake in its diabetes alliance in a potential $4.3 billion deal. AZ will pay …

Bayer in $2.9 billion Algeta deal

December 19, 2013 Sales and Marketing Algeta, Bayer, oncology, xofigo

Bayer and Algeta have decided to avoid the usual M&A dance, opting instead to agree a business deal with little …

Former Abbott head now director for UDG Healthcare

December 19, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, udg healthcare

Healthcare services provider UDG Healthcare has appointed Brendan McAtamney to be its executive director and announces two other senior hires. …

FDA pressure intensifies over cyber attack

December 18, 2013 Medical Communications, Research and Development, Sales and Marketing FDA, PhRMA, cber, digital, leak

The FDA is facing mounting pressure from a US government committee into how it allowed several of its databases to …

Pfizer executive exits leadership team

December 18, 2013 Sales and Marketing Pfizer, Read, amy schulman

A leading big pharma figurehead who was to be instrumental in Pfizer’s future plans has stepped down unexpectedly. Amy Schulman …
The Gateway to Local Adoption Series

Latest content